{"id":482,"date":"2016-12-02T12:33:10","date_gmt":"2016-12-02T11:33:10","guid":{"rendered":"http:\/\/stellbrink-partner.com\/site\/english\/?p=482"},"modified":"2016-12-14T15:46:54","modified_gmt":"2016-12-14T14:46:54","slug":"epo-decides-no-poisonous-priorities","status":"publish","type":"post","link":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/","title":{"rendered":"EPO decides: &#8220;No&#8221; to poisonous priorities"},"content":{"rendered":"<p style=\"text-align: justify;\">The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.<\/p>\n<p style=\"text-align: justify;\">Shortly summarized, this relates to the following situation. A first application is filed and discloses a specific embodiment (e.g., a screw). Later, a second application is filed and its claim relates to a more generic embodiment (e.g., means of attachment).<\/p>\n<p style=\"text-align: justify;\">The question at issue is then whether the second application can validly claim the priority of the first application, as far as a screw is concerned \u2013 that is, whether the claim has a partial priority as far as it covers the screw. This is also relevant for the following reason: If the priority of the first application could not be validly claimed, it would destroy the novelty of the second application, as a specific embodiment (the screw) deprives the more general subject-matter (means of attachment) of novelty. This is why this scenario is also known as a \u201cpoisonous priority\u201d.<\/p>\n<p style=\"text-align: justify;\">The Enlarged Board of Appeal, which is the highest instance of the European Patent Office, has now ordered that the generic term can validly claim the partial priority of the more specific term previously disclosed. See the full order <a href=\"https:\/\/register.epo.org\/application?documentId=EZRVZZP16932684&amp;number=EP98203458&amp;lng=en&amp;npl=false\">here<\/a>.<\/p>\n<p style=\"text-align: justify;\">This will be good news for patent applicants and patent practitioners!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim. Shortly summarized, this relates to the following situation. A first application is filed and discloses a specific embodiment (e.g., a screw). Later, a&hellip; <span class=\"read-btn\"><a class=\"read-more\" href=\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\">Read More<\/a><\/span><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[28,25,9,27,26],"class_list":["post-482","post","type-post","status-publish","format-standard","hentry","category-more","tag-epo","tag-partial-priorities","tag-patent","tag-poisonous-divisionals","tag-poisonous-priorities"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EPO: No to poisonous priorities | Stellbrink &amp; Partner - Patent Attorneys<\/title>\n<meta name=\"description\" content=\"Munich - The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EPO: No to poisonous priorities | Stellbrink &amp; Partner - Patent Attorneys\" \/>\n<meta property=\"og:description\" content=\"Munich - The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\" \/>\n<meta property=\"og:site_name\" content=\"Stellbrink &amp; Partner Patent Attorneys\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-02T11:33:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-12-14T14:46:54+00:00\" \/>\n<meta name=\"author\" content=\"DJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\"},\"author\":{\"name\":\"DJ\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11\"},\"headline\":\"EPO decides: &#8220;No&#8221; to poisonous priorities\",\"datePublished\":\"2016-12-02T11:33:10+00:00\",\"dateModified\":\"2016-12-14T14:46:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\"},\"wordCount\":222,\"publisher\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#organization\"},\"keywords\":[\"EPO\",\"Partial Priorities\",\"Patent\",\"Poisonous Divisionals\",\"Poisonous Priorities\"],\"articleSection\":[\"More\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\",\"url\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\",\"name\":\"EPO: No to poisonous priorities | Stellbrink & Partner - Patent Attorneys\",\"isPartOf\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#website\"},\"datePublished\":\"2016-12-02T11:33:10+00:00\",\"dateModified\":\"2016-12-14T14:46:54+00:00\",\"description\":\"Munich - The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.\",\"breadcrumb\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/stellbrink-partner.com\/site\/english\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EPO decides: &#8220;No&#8221; to poisonous priorities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#website\",\"url\":\"https:\/\/stellbrink-partner.com\/site\/english\/\",\"name\":\"Stellbrink &amp; Partner Patent Attorneys\",\"description\":\"Patent Attorneys\",\"publisher\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stellbrink-partner.com\/site\/english\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#organization\",\"name\":\"Stellbrink & Partner Patentanw\u00e4lte mbB\",\"url\":\"https:\/\/stellbrink-partner.com\/site\/english\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stellbrink-partner.com\/site\/english\/wp-content\/uploads\/sites\/2\/2016\/05\/Stellbrink__Partner-logo.png\",\"contentUrl\":\"http:\/\/stellbrink-partner.com\/site\/english\/wp-content\/uploads\/sites\/2\/2016\/05\/Stellbrink__Partner-logo.png\",\"width\":869,\"height\":79,\"caption\":\"Stellbrink & Partner Patentanw\u00e4lte mbB\"},\"image\":{\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11\",\"name\":\"DJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g\",\"caption\":\"DJ\"},\"url\":\"https:\/\/stellbrink-partner.com\/site\/english\/author\/svr1610\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EPO: No to poisonous priorities | Stellbrink & Partner - Patent Attorneys","description":"Munich - The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/","og_locale":"en_US","og_type":"article","og_title":"EPO: No to poisonous priorities | Stellbrink & Partner - Patent Attorneys","og_description":"Munich - The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.","og_url":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/","og_site_name":"Stellbrink &amp; Partner Patent Attorneys","article_published_time":"2016-12-02T11:33:10+00:00","article_modified_time":"2016-12-14T14:46:54+00:00","author":"DJ","twitter_card":"summary_large_image","twitter_misc":{"Written by":"DJ","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/#article","isPartOf":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/"},"author":{"name":"DJ","@id":"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11"},"headline":"EPO decides: &#8220;No&#8221; to poisonous priorities","datePublished":"2016-12-02T11:33:10+00:00","dateModified":"2016-12-14T14:46:54+00:00","mainEntityOfPage":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/"},"wordCount":222,"publisher":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/#organization"},"keywords":["EPO","Partial Priorities","Patent","Poisonous Divisionals","Poisonous Priorities"],"articleSection":["More"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/","url":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/","name":"EPO: No to poisonous priorities | Stellbrink & Partner - Patent Attorneys","isPartOf":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/#website"},"datePublished":"2016-12-02T11:33:10+00:00","dateModified":"2016-12-14T14:46:54+00:00","description":"Munich - The Enlarged Board of Appeal has recently issued its much awaited order in the G 1\/15 case relating to partial priorities of a generic claim.","breadcrumb":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stellbrink-partner.com\/site\/english\/epo-decides-no-poisonous-priorities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stellbrink-partner.com\/site\/english\/"},{"@type":"ListItem","position":2,"name":"EPO decides: &#8220;No&#8221; to poisonous priorities"}]},{"@type":"WebSite","@id":"https:\/\/stellbrink-partner.com\/site\/english\/#website","url":"https:\/\/stellbrink-partner.com\/site\/english\/","name":"Stellbrink &amp; Partner Patent Attorneys","description":"Patent Attorneys","publisher":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stellbrink-partner.com\/site\/english\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stellbrink-partner.com\/site\/english\/#organization","name":"Stellbrink & Partner Patentanw\u00e4lte mbB","url":"https:\/\/stellbrink-partner.com\/site\/english\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/logo\/image\/","url":"http:\/\/stellbrink-partner.com\/site\/english\/wp-content\/uploads\/sites\/2\/2016\/05\/Stellbrink__Partner-logo.png","contentUrl":"http:\/\/stellbrink-partner.com\/site\/english\/wp-content\/uploads\/sites\/2\/2016\/05\/Stellbrink__Partner-logo.png","width":869,"height":79,"caption":"Stellbrink & Partner Patentanw\u00e4lte mbB"},"image":{"@id":"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/person\/e9da2b5a5bee66bc1c6677561ea92d11","name":"DJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stellbrink-partner.com\/site\/english\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f2168a42ea163ca2c821f3f2f9cf8e35?s=96&d=mm&r=g","caption":"DJ"},"url":"https:\/\/stellbrink-partner.com\/site\/english\/author\/svr1610\/"}]}},"_links":{"self":[{"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/posts\/482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/comments?post=482"}],"version-history":[{"count":3,"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/posts\/482\/revisions"}],"predecessor-version":[{"id":489,"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/posts\/482\/revisions\/489"}],"wp:attachment":[{"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/media?parent=482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/categories?post=482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stellbrink-partner.com\/site\/english\/wp-json\/wp\/v2\/tags?post=482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}